Considerations for building and using integrated single-cell atlases
- PMID: 39672979
- DOI: 10.1038/s41592-024-02532-y
Considerations for building and using integrated single-cell atlases
Abstract
The rapid adoption of single-cell technologies has created an opportunity to build single-cell 'atlases' integrating diverse datasets across many laboratories. Such atlases can serve as a reference for analyzing and interpreting current and future data. However, it has become apparent that atlasing approaches differ, and the impact of these differences are often unclear. Here we review the current atlasing literature and present considerations for building and using atlases. Importantly, we find that no one-size-fits-all protocol for atlas building exists, but rather we discuss context-specific considerations and workflows, including atlas conceptualization, data collection, curation and integration, atlas evaluation and atlas sharing. We further highlight the benefits of integrated atlases for analyses of new datasets and deriving biological insights beyond what is possible from individual datasets. Our overview of current practices and associated recommendations will improve the quality of atlases to come, facilitating the shift to a unified, reference-based understanding of single-cell biology.
© 2024. Springer Nature America, Inc.
Conflict of interest statement
Competing interests: G.H. and H.W. are employees of Genentech whose views are their own and do not represent those of Genentech, Roche or affiliates. M.D.L. contracted for the Chan Zuckerberg Initiative, consults for CatalYm and received speaker fees from Pfizer and Janssen Pharmaceuticals. S.A.T. has consulted for or been a member of scientific advisory boards at Qiagen, Sanofi, GlaxoSmithKline and ForeSite Labs. S.A.T. is a cofounder and an equity holder of TransitionBio and EnsoCell and a SAB member of Element Biosciences and an independent non-executive director on the 10X Genomics board. S.A.T. is a part-time employee at GlaxoSmithKline. F.J.T. consults for Immunai, Singularity Bio B.V., CytoReason, Cellarity and Curie Bio Operations and has an ownership interest in Dermagnostix and Cellarity. The remaining authors declare no competing interests.
References
-
- Regev, A. et al. The Human Cell Atlas White Paper. Preprint at https://arxiv.org/abs/1810.05192 (2018). Sets out the vision and goals of the HCA. The HCA consortium aims to create comprehensive reference maps of all human cells and represents the largest single-cell atlas initiative worldwide.
-
- HuBMAP Consortium. The human body at cellular resolution: the NIH Human Biomolecular Atlas Program. Nature 574, 187–192 (2019). Lays out the framework of the HuBMAP, one of the two largest single-cell atlas initiatives to comprehensively map the human body at single-cell level. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
